ODINWELL AB
Healthcare · EUR · F
Price
€0.017
Cap
€838,109
Earnings
—
30d Trend
+0.0%
BRAIN47 SIGNAL
Raw weighted: 27×Macro 0.99 (−1%)=27
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Medium-term thesis is weak — trend and momentum are against this name
BRAIN47'S ASSESSMENT
I rate ODINWELL AB at 27/100 — a VERY WEAK reading on the Brain47 Signal. The strongest factor is risk management at 34/100. I classify this as a speculative position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
-5.6%
3 MONTHS
+6.3%
12 MONTHS
-56.4%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Medium-term thesis is weak — trend and momentum are against this name. low-risk profile and Momentum (28) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. I classify this as a speculative position — risk characteristics and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.